Health News - Top Articles for Patients - Current Health News From Leading Health Related Publications. We are committed to offering patients the latest health news and health information resources.  Click on a subject below for current health news from leading health professionals.

Crohn`s Disease

Current Health Info
Edited by Physicians
  health news

Become A Member
Enter your email:   
Crohn`s Disease Home
Overview
What is Crohn's ?
What are the causes?
Background Directory
Diagnosis
Signs and Symptoms
Symptoms Directory
Diagnostic Tests
Upper GI
Colonoscopy
Procedures/Tests Directory
Treatment
Disease Management
Medications
Medications Directory
Colectomy
Surgical Therapies
Nutrition
Supplements and Diet Control
Complications
Extraintestinal
High Risk Groups
Women
Clinical Trials
Research
Organizations
Associations/Medical Organizations Directory
Links
Support
Support/ChatGroup Directory
Crohn's Disease discussion groups
 
OTHER RESOURCES
Resource Directories
 


 
ABOUT US
About HealthyLinx
 
 
For Patients For Physicians Drug Guide About Us Sign In Register Site Map
SALES INFO: Sponsorship Market Research Content Licensing Clients Quick Quote




Search MDLinx                     





Drug Therapy for Crohn's Disease

Most people are first treated with drugs containing mesalamine, a substance that helps control inflammation. Sulfasalazine is the most commonly used of these drugs. Patients who do not benefit from it or who cannot tolerate it may be put on other mesalamine-containing drugs, generally known as 5-ASA agents, such as Asacol, Dipentum, or Pentasa. Possible side effects of mesalamine preparations include nausea, vomiting, heartburn, diarrhea, and headache.

Some patients take corticosteroids to control inflammation. These drugs are the most effective for active Crohn's disease, but they can cause serious side effects, including greater susceptibility to infection.

Drugs that suppress the immune system are also used to treat Crohn's disease. Most commonly prescribed are 6-mercaptopurine and a related drug, azathioprine. Immunosuppressive agents work by blocking the immune reaction that contributes to inflammation. These drugs may cause side effects like nausea, vomiting, and diarrhea and may lower a person's resistance to infection. When patients are treated with a combination of corticosteroids and immunosuppressive drugs, the dose of corticosteriods can eventually be lowered. Some studies suggest that immunosuppressive drugs may enhance the effectiveness of corticosteroids.

The U.S. Food and Drug Administration has approved the drug infliximab (brand name, Remicade) for the treatment of moderate to severe Crohn's disease that does not respond to standard therapies (mesalamine substances, corticosteroids, immunosuppressive agents) and for the treatment of open, draining fistulas. Infliximab, the first treatment approved specifically for Crohn's disease, is an anti-tumor necrosis factor (TNF) substance. TNF is a protein produced by the immune system that may cause the inflammation associated with Crohn's disease. Anti-TNF removes TNF from the bloodstream before it reaches the intestines, thereby preventing inflammation. Investigators will continue to study patients taking infliximab to determine its long-term safety and efficacy.

Antibiotics are used to treat bacterial overgrowth in the small intestine caused by stricture, fistulas, or prior surgery. For this common problem, the doctor may prescribe one or more of the following antibiotics: ampicillin, sulfonamide, cephalosporin, tetracycline, or metronidazole.

Diarrhea and crampy abdominal pain are often relieved when the inflammation subsides, but additional medication may also be necessary. Several antidiarrheal agents could be used, including diphenoxylate, loperamide, and codeine. Patients who are dehydrated because of diarrhea will be treated with fluids and electrolytes.

Related Links
Ileostomy, colostomy, and Ileoanal Surgery

Colectomy

What is the treatment for Crohn's Disease?


Source: National Digestive Disases Information Clearinghouse




© 1999-2005 MDLinx, All rights reserved.    Contact Us - Privacy Policy - Terms of Use - FAQ